Price $0.33 |
Market Cap
9.4M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
-
|
P/S
29.27
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-3.3K
|
FCF
-0.1
|
|
Op. Margin
-998.60%
|
Net Margin
-
|
ROE
87.90%
|
ROI
-603.20%
|
|
ROA
-136.60%
|
EPS Growth
68.20%
|
Current Ratio
0.4
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Encision Inc (ECIA) | $0.48 | - | - | 5.6M | Strong Buy |
| NantHealth Inc (NH) | $1.10 | - | - | 120.6M | Strong Buy |
| Natus Medical Inc (NTUS) | $31.55 | - | - | 1.11B | Strong Buy |
| Novelion Therapeutics Inc (USA (NVLNF) | $0.74 | - | - | 13.3M | Strong Buy |
| Ocugen Inc (OCGN) | $0.41 | - | - | 5.7M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
